Autopsy report · NCT03028987

Adaptive Immune Responses and Repertoire in Influenza Vaccination and Infection (SLVP031)

“LAIV was no longer recommended by ACIP”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 years 2 months after it had already started.
• Ran for about 1 year before it stopped.
• 10 participants enrolled.
• Results were posted on the registry 1 year 10 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Stanford University

Sponsor type

University, hospital or other

Conditions

Influenza

Interventions

Fluzone®; FluMist®

Participants

10

Sites

1

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.